Mangalam Drugs & Organics Share Price | Mangalam Drugs & Organics Stock Screener
MANGALAM
Pharmaceuticals
Share Price NSE
₹28.09
▼
-0.16 (-0.57%)
Share Price BSE
₹28.39
▲
0.19 (0.67%)
As of July 3, 2026, the Mangalam Drugs & Organics share price (NSE: MANGALAM) is ₹28.09 on NSE and ₹28.39 on BSE, down 0.57% from the previous close, with shares trading between ₹27.61 and ₹29.30, and a 52-week range of ₹23.78–₹92.46.
Analyse MANGALAM price trends and track historical price performance.
Use the Mangalam Drugs & Organics stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Mangalam Drugs & Organics Market Cap
₹44.86 Cr.
MANGALAM P/E Ratio (TTM)
-1.02
Mangalam Drugs & Organics P/B Ratio
0.47
EPS (TTM)
₹-28.05
Dividend Yield
-
Debt to Equity
0.73
MANGALAM 52 Week High
₹92.46
Mangalam Drugs & Organics 52 Week Low
₹23.78
Operating Margin
-8.00%
Profit Margin
-19.40%
MANGALAM Revenue (TTM)
₹67.00
EBITDA
₹-6.00
Net Income
₹-13.00
Total Assets
₹315.00
Total Equity
₹103.00
Mangalam Drugs & Organics Share Price Chart
Screen Mangalam Drugs & Organics share price with an interactive chart. Analyse MANGALAM price trends and volatility across different timeframes.
Mangalam Drugs & Organics Company Profile - Fundamental Screener
Screen Mangalam Drugs & Organics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MANGALAM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE584F01014
Mangalam Drugs & Organics Balance Sheet Screener
Screen MANGALAM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 |
|---|---|---|---|
| Assets | |||
| Total Assets | 315 | 366 | 334 |
| Current Assets | 156 | 199 | 176 |
| Fixed Assets | 159 | 163 | 148 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 15 | 26 | 34 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 103 | 149 | 136 |
| Share Capital | 16 | 16 | 16 |
| Reserves & Surplus | 87 | 133 | 120 |
Mangalam Drugs & Organics Income Statement Screener - Profit & Revenue Analysis
Screen Mangalam Drugs & Organics income statement and profit fundamentals.
Analyze MANGALAM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Mangalam Drugs & Organics share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 67 | 59 | 49 | 57 | 73 | 89 | 80 | 77 | 102 | 97 |
| Expenses | 73 | 60 | 52 | 62 | 63 | 80 | 71 | 68 | 91 | 90 |
| EBITDA | -6 | -1 | -3 | -5 | 10 | 9 | 9 | 8 | 12 | 7 |
| Operating Profit % | -8.00% | -3.00% | -6.00% | -8.00% | 14.00% | 10.00% | 11.00% | 11.00% | 11.00% | 7.00% |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 |
| Interest | 3 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 3 |
| Profit Before Tax | -13 | -10 | -13 | -13 | 2 | 1 | 1 | 1 | 4 | 0 |
| Tax | 0 | 0 | -5 | 1 | 2 | 0 | -2 | -2 | 0 | -1 |
| Net Profit | -13 | -10 | -7 | -14 | 0 | 1 | 3 | 3 | 4 | 1 |
| EPS | -8.48 | -6.21 | -4.64 | -8.72 | 0.04 | 0.81 | 1.70 | 1.70 | 2.23 | 0.31 |
Mangalam Drugs & Organics Cash Flow Screener - Liquidity Fundamentals
Screen MANGALAM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 43 | 4 |
| Investing Activities | -20 | -12 |
| Financing Activities | -22 | 5 |
| Net Cash Flow | 1 | -3 |
Mangalam Drugs & Organics Shareholding Pattern Screener
See Mangalam Drugs & Organics shareholding pattern with promoter, FII, and DII holdings.
Check Mangalam Drugs & Organics promoter holding and ownership changes for MANGALAM on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.65% | 50.30% | 50.30% | 50.30% | 35.64% | 50.32% | 50.32% | 50.30% |
| FII Holding | 0.32% | 0.47% | 0.53% | 0.11% | 0.13% | 0.26% | 0.21% | 0.11% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 60.14% | 44.55% | 44.53% | 45.00% | 57.52% | 44.22% | 44.70% | 44.91% |
| Other Holding | 3.89% | 4.68% | 4.63% | 4.59% | 6.70% | 5.20% | 4.77% | 4.67% |
| Shareholder Count | 25,140 | 19,697 | 19,728 | 19,881 | 21,227 | 19,173 | 19,312 | 19,508 |
Mangalam Drugs & Organics Share Dividend Screener - Share Yield Analysis
Check Mangalam Drugs & Organics dividend history with payout and yield data.
View Mangalam Drugs & Organics dividend details including ex-dates and amounts for MANGALAM stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.50 | 0.92% |
| 2017-March | ₹0.00 | 0.00% |
Mangalam Drugs & Organics Stock Index Membership
See which indices include Mangalam Drugs & Organics stock.
Check MANGALAM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Mangalam Drugs & Organics Market Events Screener - Corporate Actions
Get Mangalam Drugs & Organics corporate actions including splits, bonuses, and buybacks.
Check Mangalam Drugs & Organics stock events that may affect MANGALAM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -7.92% | ||
| Annual General Meeting | NA | -4.57% | ||
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | 3.97% |
| 2026-01-15 | 2026-01-15 | Quarterly Result Announcement | NA | 33.96% |
| 2025-11-20 | 2025-11-20 | Quarterly Result Announcement | NA | -17.31% |
| 2025-08-12 | 2025-08-12 | Extraordinary General Meeting | NA | -9.85% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -4.03% |
| 2025-05-17 | 2025-05-17 | Quarterly Result Announcement | NA | 4.63% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | 1.61% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.83% |
Mangalam Drugs & Organics Competitors Screener - Peer Comparison
Screen MANGALAM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 449,827 | 38.82 | 58,220 | 6.38% | 11,565 | 65.03 |
| Divis Laboratories | 174,081 | 69.38 | 10,560 | 8.73% | 2,520 | 43.32 |
| Torrent Pharmaceuticals | 157,634 | 71.51 | 13,886 | 20.34% | 2,138 | 66.05 |
| Cipla | 117,459 | 30.13 | 29,045 | 2.24% | 3,870 | 68.02 |
| Dr Reddys Laboratories | 114,822 | 27.10 | 33,593 | -0.44% | 3,998 | 73.77 |
| Zydus Life Science | 112,829 | 21.63 | 26,720 | 13.65% | 5,242 | 66.06 |
| Lupin | 110,115 | 20.00 | 27,488 | 19.98% | 5,345 | 66.98 |
| Mankind Pharma | 102,623 | 52.44 | 14,278 | 12.03% | 1,750 | 59.48 |
| Aurobindo Pharma | 89,879 | 25.78 | 33,385 | 3.21% | 3,376 | 65.10 |
| Laurus Labs | 80,995 | 88.02 | 6,868 | 22.01% | 890 | 70.64 |
Mangalam Drugs & Organics Company Announcements - News Screener
Screen MANGALAM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-03 | Closure of Trading Window | - |
| 2026-06-18 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-06-18 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-06-17 | Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure | - |
| 2026-05-25 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-25 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-18 | Dispatch Of Postal Ballot Notice Dated 18.05.2026 By Way Of Remote E- Voting For Taking Shareholders Approval For Reappointment Of Shri Praveen Saxena (Independent Director DIN: 03199264) For Second Term Of 5 Consecutive Years | - |
| 2026-05-16 | Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-14 | Approval Of Audited Financial Results For The Quarter Ended 31St March 2026 | - |
| 2026-05-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th May 2026 For Declaration Of Audited Financial Results(Standalone & Consolidated) Of The Company For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-06 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th May 2026 Inter-Alia To Approve Audited Financial Results(Standalone & Consolidated) Of The Company For The Period Ended 31St March 2026 | - |
| 2026-04-29 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-04-29 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-04-29 | Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-04-17 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-04-17 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2026-04-16 | Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure | - |
| 2026-04-10 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |